Cite
HARVARD Citation
Mavroudis, P. et al. (2022). A multi‐model approach to predict efficacious clinical dose for an anti‐TGF‐β antibody (GC2008) in the treatment of osteogenesis imperfecta. CPT: pharmacometrics & systems pharmacology. pp. 1485-1496. [Online].